Novo’s Wegovy Pill Wins Obesity Approval, Securing Lead in Oral GLP-1 Race
Analysts called the approval a much-needed win for Novo Nordisk, but warned that the company could struggle to grow sales once rival drugs come to market.
Novo’s Wegovy Pill Wins Obesity Approval, Securing Lead in Oral GLP-1 Race Read More »
